Hamps Bio Ltd Stock Price Today (NSE: HAMPS)

Hamps Bio Ltd

25.000.12 (0.48%)
Market Closed

Fundamental Score

...

Hamps Bio Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Hamps Bio Ltd share price today is 25.00, down 0.48% on NSE/BSE as of 22 June 2026. Hamps Bio Ltd (HAMPS) is a Small-cap company in the Other Agricultural Products sector with a market capitalisation of 21.34 (Cr). The 52-week high for HAMPS share price is N/A and the 52-week low is 13.36. The company has a Return on Equity (ROE) of 4.94% and a debt-to-equity ratio of 0.44.

Hamps Bio Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
26.51
Low
23.00
Volume
12.7K
Change
+3.69%

Hamps Bio Ltd share price chart: 3.69% return over the past month. 52-week high ₹N/A, 52-week low ₹13.36.

Hamps Bio Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
25.0025.0025.0025.004.00K (Cr)
25.1225.1225.1225.124.00K (Cr)
26.4426.4426.4426.440.00 (Cr)
26.0526.4426.0526.448.00K (Cr)
25.1925.1925.1925.198.00K (Cr)
26.5126.5126.5126.514.00K (Cr)
26.5026.5126.5026.518.00K (Cr)
25.2525.2525.2525.254.00K (Cr)
25.2525.2525.2525.254.00K (Cr)
25.9925.9925.6025.6828.00K (Cr)

Hamps Bio Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
25.1225.1225.0025.00-0.48%
24.0026.5124.0026.44+10.17%
19.8025.5018.5025.50+28.79%
16.0018.0013.3616.55+3.44%
16.5018.9516.5018.81+14.00%
20.6920.6916.0117.00-17.83%
24.0124.0118.0520.00-16.70%
25.4825.4824.5024.50-3.85%
20.2226.2520.2225.99+28.54%
55.460.000.0021.23-61.72%
53.5059.7549.8754.38+1.64%
40.9070.0034.2155.25+35.09%

AI Research Briefing

Powered by Gemini · 2026-04-15

Micro-cap pharma/food play is a high-risk gamble with weak financials and dependence on acquisitions.

Research Confidence
4.0/10Low
MICRO-CAP DARK HORSEConsolidation. 1M: -5.73%, 3M: -13.37%, 6M: 13.85%Expensive. P/E is non-existent due to losses. Industry P/E is 21.07x, making Hamps Bio unattractive.

WHAT'S HAPPENING NOW (last 2-4 weeks)

Hamps Bio completed the acquisition of HSDL Innovative Private Limited on March 25, 2026, for million in cash. HSDL Innovative reported total revenue of million for the period ending March 31, 2025.

CORE STORY (THE REAL GAME)

Micro-cap play on the fragmented market for specialized pharma and freeze-dried foods. The story hinges on inorganic growth via acquisitions and potential operating leverage.

Why Now
  • Acquisition of HSDL Innovative completed
  • Price near 52-week low
  • Agro exports from India are in high demand
Potential Catalysts
  • Successful integration of HSDL Innovative
  • Significant improvement in quarterly earnings
  • New large order wins
Key Risks
  • Micro-cap with high illiquidity risk
  • Low interest coverage of 0.12x
  • Negative YoY profit growth of -174.07%
Institutional Activity

Promoter holding steady at 71.99%. No FII/DII activity.

Macro Context

Agro exports from India are in high demand, but Hamps Bio's specific positioning is unclear.

Order Book / Expansion

Acquisition of HSDL Innovative Private Limited for ₹20.4 million completed on March 25, 2026.

Cash Flow Quality

No Free Cash Flow 5Y: ₹None Cr

3–6 Month Outlook

Next 3-6 months hinge on successful integration of HSDL Innovative and a demonstrable turnaround in profitability. Without it, expect further downside.

Primary Thesis Risk

Illiquidity and weak financials make this a potential value trap.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

4.94%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

6.68%

Returns generated on total capital deployed

Oper. Profit Margin (5Y Avg)

N/A

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Hamps Bio Ltd Valuation Check

Price to Earnings (P/E)

N/A

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

21.07x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

71.99%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-174.07%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

12.71%

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Good

Debt to Equity Ratio

0.44x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

0.12x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

N/A

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Hamps Bio Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of HAMPS across key market metrics for learning purposes.

Positive Indicators

2 factors identified

Balanced Promoter Holding (71.99%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

5 factors identified

Below-Average Return on Equity (4.94%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (6.68%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Profit Decline Concern (-174.07%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Weak Interest Coverage (0.12x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Hamps Bio Ltd vs Other Agricultural Products Peers

Peer Comparison - Other Agricultural Products

Compare Hamps Bio Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
16.4/100
25
₹21.34
4.94%
Poor
6.68%
Poor
0.4
Excellent
0.00%
LT Foods Ltd...
LTFOODS532783
67.8/100
405
₹14419.68
22.7
Average
16.70%
Good
19.18%
Good
0.4
Excellent
26.37%
Excellent
15.99%
Excellent
0.72%
KRBL Ltd...
KRBL530813
54.6/100
360
₹9182.57
15.1
Average
9.42%
Poor
11.84%
Average
0.0
Excellent
-3.15%
Poor
4.45%
Average
0.87%
44.1/100
160
₹5195.38
25.2
Average
8.59%
Poor
11.46%
Average
0.1
Excellent
10.42%
Good
3.86%
Average
0.22%
56.1/100
900
₹5132.36
16.9
Average
19.04%
Good
20.08%
Excellent
0.0
Excellent
3.36%
Average
5.30%
Good
0.50%
48.3/100
158
₹2915.20
43.0
Average
16.03%
Good
13.50%
Average
0.4
Excellent
13.84%
Good
12.44%
Good
0.00%
Sanstar Ltd...
SANSTAR544217
45.7/100
115
₹1641.27
81.7
Average
9.63%
Poor
11.76%
Average
0.0
Excellent
129.68%
Excellent
29.55%
Excellent
0.00%
42.3/100
280
₹1277.19
13.6
Average
14.19%
Average
16.71%
Good
0.1
Excellent
14.42%
Good
13.39%
Good
0.97%
52.7/100
98
₹1096.07
39.5
Average
28.81%
Excellent
21.16%
Excellent
0.3
Excellent
58.19%
Excellent
28.28%
Excellent
0.00%
57.2/100
69
₹1038.52
16.9
Average
9.89%
Poor
12.84%
Average
0.2
Excellent
7.46%
Good
7.00%
Good
1.03%
45.7/100
178
₹838.46
19.6
Average
3.92%
Poor
6.31%
Poor
0.7
Good
2.79%
Average
26.61%
Excellent
0.22%

Hamps Bio Ltd PE Ratio History

Historical price-to-earnings ratio for HAMPS — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20242.55₹82.6732.4x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Hamps Bio Ltd Quarterly Performance

Latest quarterly metrics for HAMPS — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

12.71%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-174.07%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Hamps Bio Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for HAMPS — calculated from daily price history

59RSI 14
Neutral — RSI 59

Momentum is balanced — neither overbought nor oversold.

SMA 50
21
▲ Price above SMA 50 — Short-term bullish
SMA 200
NaN
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
12K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Hamps Bio Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Hamps Bio Ltd (HAMPS) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Hamps Bio Ltd

About HAMPS (Hamps Bio Ltd)

Hamps Bio Ltd is a pioneering force in the realm of agricultural innovation, specializing in the development and distribution of cutting-edge bio-products that enhance crop yields ...and promote sustainable farming practices. Unlike traditional agricultural input suppliers, HAMPS focuses on harnessing the power of naturally derived compounds and beneficial microorganisms to create solutions that improve soil health, enhance plant resilience, and optimize nutrient uptake. Their diverse product portfolio includes bio-fertilizers, bio-pesticides, and soil conditioners meticulously formulated to meet the specific needs of various crops and geographical regions. Committed to environmental stewardship, HAMPS champions eco-friendly alternatives that minimize reliance on synthetic chemicals and contribute to a healthier planet. Beyond their core product offerings, HAMPS Bio Ltd is deeply invested in research and development, constantly exploring new frontiers in agricultural biotechnology. Their team of scientists and agronomists work tirelessly to identify novel bio-active ingredients and develop innovative formulations that address emerging challenges in the agricultural landscape. Through strategic partnerships with research institutions and agricultural universities, HAMPS fosters a collaborative ecosystem that accelerates the translation of scientific discoveries into practical solutions for farmers. This dedication to innovation ensures that HAMPS remains at the forefront of the bio-agricultural revolution, empowering farmers with the tools they need to achieve sustainable and profitable yields. HAMPS Bio Ltd distinguishes itself through its unwavering commitment to quality and customer satisfaction. All products undergo rigorous testing and quality control measures to ensure efficacy, safety, and consistency. The company provides comprehensive technical support and training to farmers, empowering them to effectively utilize HAMPS' bio-products and optimize their farming practices. Furthermore, HAMPS is committed to building long-term relationships with its customers, fostering trust and collaboration to achieve shared success. With a strong focus on sustainability, innovation, and customer-centricity, HAMPS Bio Ltd is poised to play a pivotal role in shaping the future of agriculture.

Company Details

Symbol:HAMPS
Industry:Other Agricultural Products
Sector:Other Agricultural Products

Key Leadership

Mr. Herrik Mountbaton Shah
Founder, Chairman & MD
Ms. Mitali Shrenikkumar Shah
Chief Financial Officer
Ms. Komal Jain
Company Secretary & Compliance Officer

HAMPS Share Price: Frequently Asked Questions

What is the current share price of Hamps Bio Ltd?

Hamps Bio Ltd (HAMPS) trades at ₹25.00 on NSE and BSE. Market cap ₹21.34 (Cr). Educational data only.

What is the P/E ratio of Hamps Bio Ltd?

Hamps Bio Ltd has a P/E of N/Ax vs industry average 21.07x.

What is the Bull Run score for Hamps Bio Ltd?

Hamps Bio Ltd has a Bull Run score of 16.4/100 based on 25+ financial parameters.

Does Hamps Bio Ltd pay dividends?

Hamps Bio Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Hamps Bio Ltd?

Hamps Bio Ltd has ROE of 4.94%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Hamps Bio Ltd?

Hamps Bio Ltd has debt-to-equity of 0.44.

Is Hamps Bio Ltd a good investment?

Bull Run gives Hamps Bio Ltd a score of 16.4/100. This is not investment advice — consult a SEBI-registered advisor.